Du, Fanfan http://orcid.org/0000-0001-5374-4087
Rische, Clayton H. http://orcid.org/0000-0003-3610-2116
Li, Yang http://orcid.org/0000-0002-6286-0052
Vincent, Michael P.
Krier-Burris, Rebecca A. http://orcid.org/0000-0001-9722-215X
Qian, Yuan
Yuk, Simseok A. http://orcid.org/0000-0002-6610-4940
Almunif, Sultan
Bochner, Bruce S. http://orcid.org/0000-0002-9411-6009
Qiao, Baofu http://orcid.org/0000-0001-8870-5985
Scott, Evan A. http://orcid.org/0000-0002-8945-2892
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB030629, R01EB030629, R01EB030629, R01EB030629, R01EB030629, R01EB030629, R01EB030629)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R21AI159586, R21AI159586, R21AI159586)
National Science Foundation (DMR-0520547, DMR-0520547, DMR-0520547)
Article History
Received: 11 January 2023
Accepted: 24 November 2023
First Online: 16 January 2024
Competing interests
: B.S.B. receives remuneration for serving on the scientific advisory board of Allakos, Inc., a biotechnology company developing Siglec-based therapies. He also owns stock in Allakos, Inc. He receives consulting fees from Third Harmonic Bio. He receives publication-related royalty payments from Elsevier and UpToDate. He is a co-inventor on existing Siglec-8-related patents and thus may be entitled to a share of royalties received by Johns Hopkins University during the development and potential sales of such products. B.S.B. is also a co-founder of Allakos, Inc., which makes him subject to certain restrictions under university policy. The terms of this arrangement are managed by Johns Hopkins University and Northwestern University in accordance with their conflict-of-interest policies. E.A.S., B.S.B. and C.H.R. are inventors on a patent application submitted by Northwestern University that covers the developed nanomedicine to inhibit anaphylaxis. The other authors declare no competing interests.